Chronic News and Research

RSS

FDA fast track status for Alfimeprase

Nuvelo Inc. today announced that it has been granted fast track designation by the U.S. Food and Drug Administration (FDA) for its lead product candidate, alfimeprase, for the treatment of acute peripheral arterial occlusion (PAO), or "leg attack."

23 Jan 2006

Pain in the back - mind could be the cure

Researchers in the Netherlands suggest that mental exercises could be just as effective as physically working the muscles when it comes to easing back pain.

23 Jan 2006

How to be an "expert patient" and save your hospital money

British health secretary, Patricia Hewitt, in an attempt to resolve the financial quagmire the National Health service has got itself into, is demanding that in future financial management be put ahead of clinical objectives.

23 Jan 2006

Workplace stress plays is an important risk factor for heart disease and diabetes

Stress at work is an important risk factor for the development of heart disease and diabetes, finds a study published online by the British Medical Journal.

23 Jan 2006

Metabolic syndrome - a new risk factor for impaired kidney function

A three-year multi-center study of kidney-pancreas transplant recipients has identified a new risk factor for impaired kidney function, which may help physicians refine their treatment strategies.

23 Jan 2006

Salt water treatment for cystic fibrosis both effective and cheap

Two teams of scientists working half a world apart, have identified what they believe is a simple, effective and inexpensive treatment to reduce lung problems associated with cystic fibrosis.

19 Jan 2006

X-linked agammaglobulinemia

Individuals who have a rare genetic immune system disorder that prevents them from making antibodies nevertheless appear to be moderately healthy and lead productive lives, according to results of a study by investigators at St. Jude Children's Research Hospital.

18 Jan 2006

Bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapy

In a small study from a referral center for dermatology, most patients receiving prolonged oral corticosteroids for chronic skin diseases were not receiving therapies to prevent osteoporosis that may be caused by the drug, according to an article in the January issue of Archives of Dermatology.

16 Jan 2006

Molecular disruption of hypothalamic nutrient sensing induces obesity

In their latest finding on the brain's role in controlling appetite and weight, researchers at the Albert Einstein College of Medicine have shown that reducing levels of fatty acids in the hypothalamus causes rats to overeat and become obese. Their results suggest that restoring fatty-acid levels in the brain may be a promising way to treat obesity.

16 Jan 2006

Lung transplant survival extended by Cyclosporine

According to a new study in the U.S., lung transplant patients live longer when they inhale the rejection-fighting drug Cyclosporine.

16 Jan 2006

Vaccine candidate for hepatitis C

Researchers at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) have developed a vaccine candidate for hepatitis C, leading to hope in the fight against a disease for which no vaccines are yet available.

11 Jan 2006

Depression frequent and highly persistent in 85-plus

Amongst the oldest old (85-plus), depression is frequent and highly persistent, according to a new study from The Netherlands.

10 Jan 2006

Tomato juice keeps emphysema from developing in new animal model of degenerative disease

Feeding tomato juice to mice kept them from developing emphysema after cigarette smoke exposure that was long enough to induce emphysema in a control group, Japanese researchers report in February issue of the American Journal of Physiology-Lung Cellular and Molecular Physiology.

10 Jan 2006

Approval of first immune globulin for use beneath the skin

The U.S. Food and Drug Administration (FDA) has announced the approval of the first immune globulin product for subcutaneous injection for the prevention of serious infections in patients with Primary Immune Deficiency Diseases (PIDD).

10 Jan 2006

Loyola to study for first time IV medication for osteopenia and inflammatory bowel diseases

Researchers at the Osteoporosis and Metabolic Bone Disease Center and the Division of Gastroenterology at Loyola University Health System are studying a once-yearly, 15-minute infusion of an intravenous (IV) medication in patients with osteopenia (low bone mass) and inflammatory bowel diseases (IBD) that, if proven effective, may be considered the standard of treatment.

10 Jan 2006

Non-prescription cough medicine won't help that cough

According to a panel of experts in the U.S. cough medicines bought over the counter do little good and may in fact harm children.

9 Jan 2006

Treating glaucoma early significantly reduces economic health burden

Treatments that delay the progression of glaucoma may significantly reduce the economic health burden on people with the disease and on the U.S. health system, according to a new study by researchers at Duke University Eye Center and elsewhere. Their findings appear in the January 9, 2006, issue of Archives of Ophthalmology.

9 Jan 2006